|
|
||||||||
Journal of Lipid Research, Vol 35, 1241-1250, Copyright © 1994 by Lipid Research, Inc.
D De Craemer, J Vamecq, F Roels, L Vallee, M Pauwels and C Van den Branden
Male NMRI mice were fed a diet with 10% w/w Beromegan for up to three
weeks. Beromegan is a commercial fish (salmon) oil preparation rich in
eicosapentaenoic acid and docosahexaenoic acid. Peroxisomal beta- oxidation
capacity, catalase activity, and ultrastructural morphometry of the hepatic
peroxisomes were investigated. In myocardium and kidney, catalase activity,
peroxisomal staining after catalase cytochemistry, peroxisomal morphology,
and morphometry (in myocardium) were evaluated. In liver, we found a
significant increase in peroxisomal beta- oxidation, catalase activity, and
peroxisomal number already after 3 days of dietary treatment. These changes
were more pronounced after 3 weeks. Peroxisomal size was not changed.
Positive correlations were found between peroxisomal enzyme activities and
the number but not the size of the peroxisomes, and between catalase
activity and beta- oxidation capacity. The mean peroxisomal diameter per
animal was inversely proportional to catalase activity measured in
homogenate. In myocardium, catalase activity was increased with duration of
fish oil feeding. Peroxisomal staining, number, and size were also
increased when compared to controls. In kidney, no alterations were
observed. Our results indicate a beneficial effect of a diet supplemented
with fish oil on the peroxisomal metabolism in liver and myocardium; it
differs from the changes induced by xenobiotic peroxisome proliferation.
ARTICLES
Peroxisomes in liver, heart, and kidney of mice fed a commercial fish oil preparation: original data and review on peroxisomal changes induced by high-fat diets
Menselijke Anatomie & Embryologie, Vrije Universiteit Brussel, Belgium.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. H. Lash and J. C. Parker Hepatic and Renal Toxicities Associated with Perchloroethylene Pharmacol. Rev., May 11, 2001; (2001) 2. [Abstract] [Full Text] |
||||
![]() |
C. K. Sen, M. Atalay, J. Agren, D. E. Laaksonen, S. Roy, and O. Hanninen Fish oil and vitamin E supplementation in oxidative stress at rest and after physical exercise J Appl Physiol, July 1, 1997; 83(1): 189 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Lash and J. C. Parker Hepatic and Renal Toxicities Associated with Perchloroethylene Pharmacol. Rev., June 1, 2001; 53(2): 177 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dallongeville, E. Bauge, A. Tailleux, J. M. Peters, F. J. Gonzalez, J.-C. Fruchart, and B. Staels Peroxisome Proliferator-activated Receptor alpha Is Not Rate-limiting for the Lipoprotein-lowering Action of Fish Oil J. Biol. Chem., February 9, 2001; 276(7): 4634 - 4639. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |